These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7371708)

  • 41. Can open-label studies demonstrate efficacy in improving sexual function?
    Michel MC; Meissner A
    Int J Impot Res; 2009; 21(4):265; author reply 265-6. PubMed ID: 19603043
    [No Abstract]   [Full Text] [Related]  

  • 42. Misuse of randomized clinical trials.
    Hofmann F
    Man Med; 1979; 4(2):138-42. PubMed ID: 12083135
    [No Abstract]   [Full Text] [Related]  

  • 43. Comment on 'Mobile phone headache: a double blind, sham-controlled provocation study'.
    Chu MK
    Cephalalgia; 2010 Jun; 30(6):767. PubMed ID: 20511213
    [No Abstract]   [Full Text] [Related]  

  • 44. Assessing response to methylphenidate for attention deficit disorder.
    Wolraich M
    J Pediatr; 1989 May; 114(5):902-3. PubMed ID: 2715907
    [No Abstract]   [Full Text] [Related]  

  • 45. Principles and pitfalls of clinical trials design.
    Jeffcoat MK
    J Periodontol; 1992 Dec; 63(12 Suppl):1045-51. PubMed ID: 1479524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Should placebo-controlled trials be abolished?
    Feinstein AR
    Eur J Clin Pharmacol; 1980 Jan; 17(1):1-4. PubMed ID: 7371694
    [No Abstract]   [Full Text] [Related]  

  • 47. Hypothesis testing vs. statistical estimation procedures in caries clinical trials.
    Fertig JW
    J Dent Res; 1984 May; 63 Spec No():808-13. PubMed ID: 6586785
    [No Abstract]   [Full Text] [Related]  

  • 48. Being a patient in a drug trial: do you lose something? [proceedings].
    Priest RG
    Neuropharmacology; 1977; 16(7-8):532. PubMed ID: 335271
    [No Abstract]   [Full Text] [Related]  

  • 49. The controlled, randomised clinical trial -- sacred duty or sacred cow?
    de Dombal FT
    Klin Wochenschr; 1980 Jul; 58(13):649-52. PubMed ID: 7442078
    [No Abstract]   [Full Text] [Related]  

  • 50. [Errors of methodology. General considerations seen by the cardiologist].
    Orzan F
    G Ital Cardiol; 1985 Jun; 15(6):625-7. PubMed ID: 4065482
    [No Abstract]   [Full Text] [Related]  

  • 51. [Roaming through methodology. XII. Pragmatic and pathophysiologic trials: a question of goal formulation].
    Algra A; van der Graaf Y
    Ned Tijdschr Geneeskd; 1999 Mar; 143(10):514-7. PubMed ID: 10321260
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Present and future of trial design].
    Vargas Vorácková F
    Rev Invest Clin; 1990 Jul; 42 Suppl():36-8. PubMed ID: 19256131
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of two-period crossover design in a multicenter clinical trial.
    Castellana JV; Patel HI
    Biometrics; 1985 Dec; 41(4):969-77. PubMed ID: 3830261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inert placebo versus active medication. Patient blindability in clinical pharmacological trials.
    Bystritsky A; Waikar SV
    J Nerv Ment Dis; 1994 Sep; 182(9):485-7. PubMed ID: 8083675
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Multiple practice research. Experience with some methods].
    Bennedsen H; Nielsen JV
    Ugeskr Laeger; 1979 May; 141(22):1482-4. PubMed ID: 377745
    [No Abstract]   [Full Text] [Related]  

  • 56. Statistical management of data in clinical research.
    Fleiss JL; Kingman A
    Crit Rev Oral Biol Med; 1990; 1(1):55-66. PubMed ID: 2101261
    [No Abstract]   [Full Text] [Related]  

  • 57. Hemodialysis in chronic schizophrenics.
    Schulman A; Wetterberg L; Asaba H; Schulz SC; Van Kammen DP; Meurice E; Nedopil N; Splendiani G
    Arch Gen Psychiatry; 1984 Aug; 41(8):817-9. PubMed ID: 6378119
    [No Abstract]   [Full Text] [Related]  

  • 58. [Problems in testing new drugs in the hospital and general practice (phase III)].
    Blumenbach L
    Med Welt; 1981 Feb; 32(7):210-2. PubMed ID: 7207155
    [No Abstract]   [Full Text] [Related]  

  • 59. To throw the baby out with the bathwater: double blinding for specific oral tolerance induction.
    Longo G; Berti I; Barbi E
    Allergy; 2007 Jan; 62(1):82; author reply 83. PubMed ID: 17156347
    [No Abstract]   [Full Text] [Related]  

  • 60. Yohimbine and psychogenic impotence.
    Lancet; 1987 Nov; 2(8567):1088. PubMed ID: 2889995
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.